中央媒介による胃腸痛みの疾患
Shin Fukudo1, Qasim Aziz2, Douglas A Drossman3
1Tohoku University Graduate School of Medicine, Research Center for Accelerator and Radioisotope Science, Tohoku University, Sendai, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Japan.
Gastroenterology
|February 15, 2026
まとめ
この研究では,胃腸の痛みの3つの中心的な障害について詳細に述べています:中心的に媒介された腹の痛み症候群,腹の片頭痛,およびオピオイド誘発の胃腸症候群. 効果的な管理には,薬物療法,行動療法,そして強い医師と患者の関係が含まれます.
科学分野:
- 胃腸内科 胃腸内科
- 神経科学は神経科学である.
- 痛み 薬 薬剤 痛み 薬剤 薬剤
背景:
- 中央媒介性胃腸の痛み障害は,ますます認識されています.
- これらの状態には,中枢神経系における内臓の痛み信号の処理が変化することが含まれます.
研究 の 目的:
- 3つの中心的に媒介された胃腸の痛み障害を特定し,記述する.
- 疫学,病理生理学,臨床評価,治療の選択肢について概要を述べる.
主な方法:
- 中央媒介性腹痛症候群,腹部片頭痛,麻薬性腸症候群/オピオイド誘発性胃腸過敏症候群に関する既存の文献のレビュー.
- 病理生理学,臨床プレゼンテーション,治療戦略に関する情報の合成.
主要な成果:
- 中央介腹痛症候群は,中央の感受性によって引き起こされる,生理的な出来事と関連しているか否かに関わらず,慢性的な痛みとして現れる.
- 腹部偏頭痛は,成人における激しい腹痛の繰り返し,ステレオタイプ的なエピソードによって特徴付けられます.
- 麻酔性腸症候群/オピオイド誘発性胃腸ハイパーアルゲシアは,オピオイド使用でパラドックスな痛み増加を伴う.
結論:
- 効果的な管理には,薬剤療法,脳腸行動療法,神経調節を含むマルチモダルのアプローチが必要です.
- 医師と患者の強い関係は,治療の成功に不可欠です.
- 中央の感受性を理解することは,これらの複雑な疼痛障害に対処するための鍵です.
キーワード:
腹部偏頭痛 腹部偏頭痛 腹部偏頭痛 腹部偏頭痛 腹部偏頭痛中央の感受性を高めること.中央媒介腹痛症候群 (Centerally mediated abdominal pain syndrome) とは,中央媒介腹痛症候群 (Centerally mediated abdominal pain syndrome) とは,中央媒介腹痛症症候群 (Centerally mediated abdominal pain syndrome) とは,中央媒介腹痛症症候群 (Centerally mediated abdominal pain syndrome) とは,中央媒介腹痛症症候群 (Centerally mediated abdominal pain syndrome) とは,中央媒介腹痛症症候群 (Centerally mediated abdominal pain syndrome) とは,中央媒介腹痛症症候群 (Centerally mediated abdominal pain syndrome) とは,中央媒介腹痛症候群 (Centerally mediated abdominal pain syndrome) とは,中央媒介腹痛症症症候群 (Centerally mediated abdominal pain syndrome) とは,中央媒介腹痛症症候群 (Centerally mediated abdominal pain syndrome) とは,麻酔性腸症候群/オピオイド誘発性胃腸ハイパーアルゲシア関連する概念動画
Other Disorders of Digestive System
1.5K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.5K
Irritable Bowel Syndrome I: Introduction
1.2K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.2K
Gastrointestinal Motility Disorders
1.3K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.3K
Chronic Bowel Disorders: Introduction
817
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
817
Drugs for Treatment of Diarrhea-Predominant IBS
754
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
754
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
649
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
649


